AB Sciex has combined its chromatography arm with the capillary electrophoresis (CE) business from Beckman Coulter.
The move brings together Beckman Coulter’s expertise in microscale separation with the expertise in microfluidics of the Eksigent chromatography team of AB Sciex.
It includes the transition of personnel as well as CE technologies and resources from Beckman Coulter Life Sciences to AB Sciex ? two leading life science companies that are both owned by Danaher Corporation.
“We are bringing together the best in CE with the best in nano LC and micro LC as a unified team to broaden the range of solutions available to our customers,” said Rainer Blair, president of AB Sciex.
“By integrating the Beckman Coulter CE team into the Sciex separations business, we will be able to take CE and our chromatography solutions to a whole new level. We are committed to investing in our separations business for long-term success.”
The Eksigent LC team of the Sciex separations business and the CE team of Beckman Coulter, a leader in benchtop capillary electrophoresis, will work together in future to develop breakthrough, integrated applications that provide fast and efficient separations of drugs, drug metabolites, organic acids, amino acids, low molecular weight amines, peptides, nucleic acids and nucleosides.
Among the synergies is the combination of CE technology and mass spectrometry (MS) technology. CE-MS allows researchers to expand the range of analytes detected while improving overall assay sensitivity.
The selectivity of CE in front-end separation further enables the characterisation of intact proteins, their isoforms, cleaved fragments and complexes. CE-MS provides information that is complementary to nano LC for proteomics research.
